Effectiveness of a publicly funded pneumococcal vaccination program against invasive pneumococcal disease among the elderly in Victoria, Australia

Vaccine

Volumn 23, Issue 2, 2004, Pages 132-138

  Andrews, Ross M ^a,b,e   Counahan, Megan L ^b   Hogg, Geoff G ^c   McIntyre, Peter B ^d  

^a The Australian National University   (Australia)

^b Australia ^*  (Australia)

^c Department of Obstetrics   (United States)

^d NATIONAL CENTRE FOR IMMUNISATION RESEARCH AND SURVEILLANCE   (Australia)

^e Ctr Intl Child Hlth Murdoch C   (Australia)

Author keywords

Elderly; Invasive pneumococcal disease; Polysaccharide pneumococcal vaccine

Indexed keywords

PNEUMOCOCCUS VACCINE;

ACCURACY; AGE DISTRIBUTION; AGED; ANALYTIC METHOD; ARTICLE; AUSTRALIA; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG EFFICACY; EPIDEMIOLOGICAL DATA; FINANCIAL MANAGEMENT; HUMAN; MASS IMMUNIZATION; MASS SCREENING; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION;

AGED; AUSTRALIA; HUMANS; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL; POPULATION SURVEILLANCE; PUBLIC HEALTH; VACCINATION;

EID: 8644254431     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.06.016     Document Type: Article

References (27)

1. D.S. Fedson, J.A. Scott, and G. Scott The burden of pneumococcal disease among adults in developed and developing countries: what is and is not known Vaccine 17 Suppl 1 1999 S11 S18
2. P.B. McIntyre, R.E. Gilmour, G.L. Gilbert, A.M. Kakakios, and C.M. Mellis Epidemiology of invasive pneumococcal disease in urban New South Wales Med. J. Aust. 173 Suppl 2000 S22 S26
3. G.G. Hogg, J.E. Strachan, and R.A. Lester Invasive pneumococcal disease in the population of Victoria Med. J. Aust. 173 Suppl 2000 S32 S35
4. National Health, Medical Research Council The Australian immunisation handbook 8th edn. 2003 Australian Government Department of Health and Ageing Canberra
5. T. Jefferson, and V. Demicheli Polysaccharide pneumococcal vaccines BMJ 325 7359 2002 292 293
6. P. Mangtani, F. Cutts, and A.J. Hall Efficacy of polysaccharide pneumococcal vaccine in adults in more developed countries: the state of the evidence Lancet Infect. Dis. 3 2 2003 71 78
7. M.J. Fine, M.A. Smith, and C.A. Carson Efficacy of pneumococcal vaccination in adults A meta-analysis of randomized controlled trials Arch. Intern. Med. 154 23 1994 2666 2677
8. B.G. Hutchison, A.D. Oxman, H.S. Shannon, S. Lloyd, C.A. Altmayer, and K. Thomas Clinical effectiveness of pneumococcal vaccine. Meta-analysis Can. Fam. Physician 45 1999 2381 2393
9. R.A. Moore, P.J. Wiffen, and B.A. Lipsky Are the pneumococcal polysaccharide vaccines effective? Meta-analysis of the prospective trials BMC Fam. Pract. 1 1 2000 1
10. C. Cornu, D. Yzebe, P. Leophonte, J. Gaillat, J.P. Boissel, and M. Cucherat Efficacy of pneumococcal polysaccharide vaccine in immunocompetent adults: a meta-analysis of randomized trials Vaccine 19 32 2001 4780 4790
11. L. Watson, B.J. Wilson, and N. Waugh Pneumococcal polysaccharide vaccine: a systematic review of clinical effectiveness in adults Vaccine 20 17-18 2002 2166 2173
12. K. Dear, J. Holden, R. Andrews, and D. Tatham Vaccines for preventing pneumococcal infection in adults Cochrane Database Syst. Rev. 4 2003 CD000422
13. E.D. Shapiro, and J.D. Clemens A controlled evaluation of the protective efficacy of pneumococcal vaccine for patients at high risk of serious pneumococcal infections Ann. Intern. Med. 101 3 1984 325 330
14. E.D. Shapiro, A.T. Berg, and R. Austrian The protective efficacy of polyvalent pneumococcal polysaccharide vaccine N. Engl. J. Med. 325 21 1991 1453 1460
15. R.V. Sims, W.C. Steinmann, J.H. McConville, L.R. King, W.C. Zwick, and J.S. Schwartz The clinical effectiveness of pneumococcal vaccine in the elderly Ann. Intern. Med. 108 5 1988 653 657
16. J.C. Butler, R.F. Breiman, J.F. Campbell, H.B. Lipman, C.V. Broome, and R.R. Facklam Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations JAMA 270 15 1993 1826 1831
17. R. Andrews, R. Lester, and L. Roberts Validation of self reported pneumococcal vaccination coverage among the elderly Communicable Disease Control Conference 2001 Canberra, Abstract no. 62 2001
18. P. Roche, and V. Krause Invasive pneumococcal disease in Australia Commun. Dis. Intell. 26 4 2002 505 519
19. D. Guris, P.M. Strebel, R. Tachdjian, B. Bardenheier, M. Wharton, and S.C. Hadler Effectiveness of the pertussis vaccination program as determined by use of the screening method: United States J. Infect. Dis. 176 2 1997 456 463
20. J.M. White, C.K. Fairley, D. Owen, R.C. Matthews, and E. Miller The effect of an accelerated immunisation schedule on pertussis in England and Wales Commun. Dis. Rep. CDR Rev. 6 6 1996 R86 R91
21. A. Herceg The decline of Haemophilus influenzae type b disease in Australia Commun. Dis. Intell. 21 13 1997 173 176
22. R.T. Chen, and W.A. Orenstein Epidemiologic methods in immunization programs Epidemiol. Rev. 18 2 1996 99 117
23. P. Armitage, and G. Berry Statistical methods in medical research 1994 Blackwell Science Oxford
24. C.V. Broome, R.R. Facklam, and D.W. Fraser Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine N. Engl. J. Med. 303 10 1980 549 552
25. Centers for Disease Control and Prevention. Epi Info 6. A word processing, database and statistics program for Public Health. 6.04d ed. Atlanta, Georgia, USA: Centers for Disease Control and Prevention; 2001.
26. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1997;46(RR-8):1-24.
27. M. Liu, R. Andrews, J. Stylianopoulos, C. Ferreira, G. Hogg, and N. Pyper Invasive pneumococcal disease among children in Victoria Commun. Dis. Intell. 27 3 2003 362 366